Cardiovascular Systems traded at $14.62 this Tuesday June 28th, decreasing $0.19 or 1.28 percent since the previous trading session. Looking back, over the last four weeks, Cardiovascular Systems lost 10.09 percent. Over the last 12 months, its price fell by 65.87 percent. Looking ahead, we forecast Cardiovascular Systems to be priced at 14.57 by the end of this quarter and at 13.42 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Terumo 4,093.00 -18.00 -0.44% -9.08%
Abiomed 249.08 -5.70 -2.24% -20.49%
Abbott 106.97 -2.11 -1.93% -8.74%
AngioDynamics 19.24 -0.50 -2.53% -28.85%
AtriCure 39.66 -1.05 -2.58% -49.99%
Baxter International 65.25 -1.46 -2.19% -20.29%
Becton, Dickinson and Co. 244.53 -5.57 -2.23% -0.96%
Boston Scientific 37.50 -0.32 -0.85% -13.25%
Artivion Inc 18.64 -0.66 -3.42% -34.62%
Cardiovascular Systems 14.62 -0.19 -1.28% -65.87%
Dexcom 74.70 -1.90 -2.48% -82.50%
Edwards Lifesciences 94.73 -2.08 -2.15% -8.55%
Globus Medical 57.55 -1.16 -1.98% -24.63%
Hologic 69.78 -1.68 -2.35% 1.35%
Inogen 24.42 -1.21 -4.72% -62.70%
Intuitive Surgical 201.99 -5.95 -2.86% -78.06%
J&J 176.94 -5.18 -2.84% 7.87%
Medtronic 89.20 -1.27 -1.40% -28.38%
Merit Medical Systems 53.77 -1.11 -2.02% -16.66%
NuVasive 49.62 -1.26 -2.48% -27.04%
Insulet 226.21 -2.00 -0.88% -20.19%
ResMed 211.27 -1.35 -0.63% -14.22%
Stryker 197.80 -5.33 -2.62% -24.05%
Teleflex 253.26 -6.30 -2.43% -38.02%
Tandem Diabetes Care 60.34 -0.65 -1.07% -39.77%
Zimmer Biomet Holdings Inc 106.48 -2.03 -1.87% -33.94%

Indexes Price Day Year
USND 11182 -343.01 -2.98% -23.04%
US2000 1739 -32.90 -1.86% -24.69%

Cardiovascular Systems
Cardiovascular Systems, Inc. is a medical technology company, which is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company has developed patented orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), which is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.